The present studies described an investigation for the interaction of N-terminal membrane anchor domain of thromboxane A 2 synthase (TXAS) with its substrate analog in a membrane-bound environment using 2D NMR technique. TXAS and prostaglandin I 2 synthase (PGIS) respectively convert the same substrate, prostaglandin H 2 (PGH 2 ) to thromboxane A 2 (TXA 2 ) and prostaglandin I 2 (PGI 2 ), which have opposite biological functions. Our topology studies have indicated that the N-terminal region of TXAS has longer N-terminal endoplasmic reticulum (ER) membrane anchor region compared to the same segment proposed for PGIS. The differences in their interaction with the ER membrane may have an important impact to facilitate their common substrate, PGH 2 across the membrane into their active sites from luminal to cytoplasmic side of the ER. To test this hypothesis, we first investigated the interaction of the TXAS N-terminal membrane anchor domain with its substrate analog. A synthetic peptide corresponding to the N-terminal membrane anchor domain (residues 1-35) of TXAS, which adopted a stable helical structure and exhibited a membrane anchor function in membrane-bound environment was used to interact with a stable PGH 2 analog, U44069. High-resolution 2D NMR experiments, NOESY and TOCSY were performed to solve the solution structures of U44069 in a membrane-mimicking environment using dodecylphosphocholine (DPC) micelles. Different In addition, combination of the structural information of U44069 and U46619 was able to simulate a solution structure of the unstable TXAS and PGIS substrate, PGH 2 .
INTRODUCTION
Eicosanoids are a family of bioactive, oxygenated metabolites of polyunsaturated fatty acids. The major eicosanoids synthesized by vascular smooth muscle, endothelium and platelets are prostaglandins and thromboxane (1, 2) . These compounds are formed via the "cyclooxgenase" pathway from arachidonic acid (AA) in three steps (1, 3) : (a) stimulus-induced mobilization of AA from membrane phosphoglycerides; (b) conversion of AA to the prostaglandin endoperoxide, PGH 2 , by PGHS on ER lumen (4-6); and (c) isomerization of PGH 2 to biologically active endproducts prostaglandin D 2 (PGD 2 ), prostaglandin E 2 (PGE 2 ), PGI 2 or TXA 2 by individual synthases likely on cytoplasmic side of the ER (3, (7) (8) .
TXA 2 produced from PGH 2 by TXAS has been implicated in various pathophysiological conditions as a proaggregatory and vasoconstricting mediator (9, 10) . PGH 2 is also converted to PGI 2 (prostacyclin) by PGIS. PGI 2 is the main AA metabolite in vascular wall and has opposing biological properties to TXA 2 , representing the most potent endogenous inhibitor of platelet aggregation (11) . PGI 2 is also a strong anti-hypertensive agent through its vasodilatory effect on vascular beds. PGIS is mainly present in vascular endothelial cells and smooth muscle cells (12) (13) (14) (15) .
As PGI 2 and TXA 2 play important roles in physiological and pathological actions, both PGIS and TXAS and the receptors of PGI 2 and TXA 2 have become important targets for pharmacological intervention. Studies of the structure/function relationship of PGIS and TXAS are important to by guest on November 6, 2017 http://www.jbc.org/ Downloaded from determine the interaction of the N-terminal peptide with a PGH 2 analog, U44069 in membranemimicking environment using high-resolution 2D NMR technique. 3D structure of U44069 in DPC micelles was determined and its conformation change induced by the N-terminal membrane anchor domain of TXAS was identified. In addition, a solution structure of the unstable substrate, PGH 2 was simulated using a combination of the solution structural information of U44069 and U46619. Peptide Synthesis ---A peptide corresponding to TXAS N-terminal 35 residues (TXASLP1) were synthesized manually using fluorenylmethoxycarbonyl-polyamide solid phase methods (20) (21) (22) . After cleavage with TFA, the peptides were purified to homogeneity by HPLC on a Vydac C 4 reversed phase column with a gradient of 0 to 80% acetonitrile in 0.1% TFA.
EXPERIMENTAL PROCEDURES

Materials
Molecular weights of the purified peptides were determined by mass spectrometry (23) .
NMR Sample Preparation ---The HPLC-purified peptide, U44069 and U46619 were dissolved in water and lyophilized three times to completely remove TFA and acetonitrile and then dissolved in 0.02 M sodium phosphate buffer, pH 6.0. The samples were lyophilized and Calculation of Structures ---The overall structures of the U46619, U44069 with or without TXASLP1 peptide in H 2 O or DPC-d 38 were determined through the use of the interproton and sequential NOEs from the NOESY spectrum. The NOE cross-peaks were first assigned and the volumes were then calculated. Felix 97 program was used for converting the volumes into upper bonds of the interproton distances as the NOE constraints, which were used for the structure calculations. The energy refinement calculations including restrained energy minimization/dynamics were carried out in the best distance geometry structures using Discover programs within the Insight II package (Molecular Simulation, Inc., San Diego, CA). 2 Analogs ---2D NMR spectra, NOESY (Fig. 2 ) and TOCSY (data not shown) of the two PGH 2 analogs, U44069 and U46619 were recorded in H 2 O with 10% acetonitrile-d 3 . The proton resonances assignments for the PGH 2 analogs were accomplished using the standard sequential assignment technique based on the proton chemical shifts (24) (25) (26) (27) .
RESULTS
NMR Assignment of PGH
The assignment procedures involve the identification of spin systems using TOCSY spectra (28, 29) and sequential assignment using NOESY spectra (30) . The major different assignments for U44069 and U46619 were at the positions of H9 and H11 protons in both NOESY spectra due to the structural difference of the two molecules for the position of oxygen (Fig. 2) . The complete proton resonance assignments for the U44069 and U46619 were summarized in Table 1 . The identification of interproton NOE cross-peaks allowed further construction of 3D structures of the analogs and showed the detail structural differences of the two analogs in solution.
3D Solution Structure of U44069 and U46619 ---
The NOE cross-peak volumes that were assigned from the NOESY spectra of U44069 and U46619 described above were first calculated and converted into upper bonds of the interproton distances as NOE constraints (Table 2) by Auto-assignment program within Felix 98 package using restricted distance of H2 and H3 of the analogs as a standard. Those NOE constraints were then used for the structural calculation on the basis of the initial structures created by Biopolymer program within Insight II package. 20 NOE constraints ( Fig. 2B ) from the NOESY spectrum for U44069 and 23 NOE constraints ( Fig. 2A) for the U46619 which include two inter-side chain NOEs (H6/H18 and H14/H4) were obtained and used as distance restraints for the structural calculation that agree with the data using Insight II program. The calculation includes energy minimization that carried out using NOE constraints and distance range and force were set to 0.1 Å and 800 respectively. The 3D structural models of two PGH 2 analogs were constructed, energy-minimized and then used to run dynamics which provide the simulation of the motion of atoms at temperature of 300K (room temperature) and force of 80. After 2000 iterations, eleven 3D structural models of two PGH 2 analogs have been built (Fig. 3A, B ). In addition, the average conformations of two analogs were superimposed for by guest on November 6, 2017 http://www.jbc.org/ Downloaded from the comparison (Fig. 3C) . The structural differences observed was the little turn of the head part conformations of the analogs and the oxygen position was at C-9 in U44069 and at C-11 in U46619. The hairpin structures of both analogs remain almost the same.
Determination of 3D Structure of U44069 in Membrane-mimicking Environment ---
Current crystallographic (4, 5) and membrane topological studies for PGHS (6, 31), TXAS (7, 8) and PGIS (17) suggested that PGH 2 is produced in luminal side of the ER membrane and then crosses the ER membrane and presents to the active sites of TXA 2 or PGI 2 synthase on cytoplasmic side of the ER. In this case the initial docking conformations of the hydrophobic PGH 2 analogs must be in membrane environment. To mimic the membrane environment, 2D NMR spectra, NOESY (Fig. 4) and TOCSY (data not shown) of the U44069 were recorded in a membrane-mimicking environment using dueture DPC micelles which is a membrane mimetic reagent with a structure accepted to resemble that of membrane phospholipid. The complete assignment of proton resonances of U44069 (Fig. 4) was made using the same strategy for the spectra recorded in H 2 O solution (Fig. 2B ). 17 NOE constraints including two inter-side chain NOEs (Table 2 ) from the NOESY spectrum that were calculated as described above were used as distance constraints for 3D structural calculation using Felix and Insight II program package. Fig. 7A shows the overlay of eleven 3D structures obtained from the structural calculations for U44069 in DPC micelles. This PGH 2 analog in the membrane-mimicking environment adopts similar conformation compared to that of the analog in solution (Fig. 5) .
Conformation change of U44069 induced by the interaction with TXAS LP1 peptide ---
Under the membrane-mimicking environment using DPC micelles, 2D NMR spectrum for U44069 was recorded in the presence of the synthetic peptide corresponding to the first 35 residues of the TXAS N-terminal membrane anchor domain. The 2D NMR spectrum was also performed for the peptide itself. The assignment of proton resonances of U44069 in the presence of peptide was made by comparison with the assignment of the analog or the peptide itself.
Several cross-peaks ( 1 HC/H8, 2 HC/H8, 2 HC/H4, H15/H11) from the U44069 structures appeared in NOESY spectrum of the mixture of U44069 and the peptide but were absent from the NOESY spectrum of U44069 or the peptide alone in same condition (Fig. 6 ). This indicates that the conformation change of U44069 was resulted from the interaction with the peptide. By constructing the 3D structure of U44069 using the method described above, detail conformation change upon the interaction with the TXAS membrane anchor domain can be identified. 24 NOE constraints including the two inter-side chain NOEs (Table 2 ) obtained from NOESY spectrum of U44069 and peptide mixture were used as distance restraints and the structure calculation was carried out within the Discover program of Insight II package. 3D conformation of U44069 with the interaction of the peptide was then created under membrane-mimicking environment (Fig.   7B ). To show the differences between the structure of U44069 with the peptide and without the peptide constructed above (Fig. 7A) , the two models were superimposed (Fig. 7C) . The hairpin structure of U44069 alone was widely opened with a distance of 8.25 Å away. After the interaction with the peptide, the hairpin structure of U44069 became closer with a distance change from 8.25Å to 4.93Å.
Identification of the intermolecular contacts between U44069 and the TXAS peptide ---
By comparison of the NOESY spectra of U44069 in the presence and absence of the TXAS peptide, and the peptide alone, a cross-peak only appeared in the NOESY spectrum of U44069 in the presence of the peptide was identified (Fig. 9) . The D1 position of the cross-peak is belonged to H9 of U44069 (Fig. 9) . Through complete assignments of the 2D NMR spectra, TOCSY, by guest on November 6, 2017 http://www.jbc.org/ Downloaded from NOESY and DQF-COSY of the TXAS N-terminal peptide (the data will be published separately), the D2 position of the cross-peak is identified to Val 16 of the peptide (Fig. 9) .
DISCUSSION
Crystallographic studies of detergent-solubilized PGHS-1 and -2 (4, 5) and topology studies suggest that the catalytic domains of the synthases are lied on the luminal side of the ER, and The conformation of U44069 changed by the present of the membrane anchor domain of TXAS in DPC micelles (Fig. 7) provided an evidence of the interaction between the TXAS domain and the PGH 2 analog. Specially, the hairpin distance of U44069 changed from 8.25 Å to 4.93 Å (Fig. 7C) suggested that the membrane anchor domain may play an important role in facilitation or guiding of its substrate to the active site channel of TXAS by reducing three dimensional size of PGH 2 formed a compact conformation allowing to dock into the active site with lower energy.
The interaction between U44069 and TXASLP1 was determined by the extra peak found in the NOESY spectrum of U44069 in the presence of the peptide (Fig. 9C) . This further suggested that the TXAS N-terminal membrane anchor segment is involved for the initial substrate recognition. The overall structures of U44069 and U46619 (Fig. 1 ) are identical to PGH 2 except for one endoperoxide oxygen was replaced with carbon at C-11 and C-9 position, respectively (Fig.   1 ). The 3D structures of U44069 and U46619 determined provided complemented structural information for the modified endoperoxide of PGH 2 . The C-9 endoperoxide structural information is available from the structure of U44069 and the C-11 endoperoxide structure is provided from U46619. Combination of the solution structures of U44069 and U46619 provided full 3D solution structural information for PGH 2 , which has difficulty to be characterized for its solution structure due to the instability in solution. The initial structure of PGH 2 was first built using Biopolymer program with the endoperoxide at C-9 and C-11 position. Due to the endoperoxide of U44069 is at C-9 position, the constraints of U44069 from the NOESY spectrum of proton distance from H1 to H10 (7 constraints) were used. As the position of endoperoxide is at C-11 for U46619, the constraints of proton distance from H8 to H20 were extracted from the NOESY spectrum of U46619 (11 constraints). Total 18 constraints were used together for the structural calculation and the energy minimization and dynamic studies were carried out using Discover program within Insight II package as described above. The constructed 3D solution model of PGH 2 was showed in Fig. 8 . The simulated solution structure of PGH 2 can be used as an initial structure for further structural characterization of the interaction between the synthases and PGH 2 . were obtained by dynamic studies using the corresponding cross peak constraints from NOESY spectra (Fig. 6 ). (C) Superimposed of the 3D structures of U44069 without (light line) and with (dark line) the peptide segment. The distance of the hairpin structure with 8.25 Å wide in U44069 was changed to 4.93 Å after the addition of the TXAS peptide. 4.62 *All proton definitions see Fig. 1 .
